Acceleration of Apoptotic Cell Death After the Cleavage of Bcl-XL Protein by Caspase-3-like Proteases
Overview
Authors
Affiliations
Interleukin-2 (IL-2)-dependent T cell clone CTLL-2 underwent apoptosis by deprivation of IL-2 from culture medium. The decrease in the anti-apoptotic Bcl-XL protein level was observed during apoptosis after IL-2 withdrawal. We found that Bcl-XL protein was cleaved to produce two 18 kDa fragments during CTLL-2 cell apoptosis. When the activation of caspases was suppressed by overexpressing human Bcl-2 protein or by the addition of caspase inhibitors, cleavage of Bcl-XL protein was suppressed in vivo. Bcl-XL protein cleavage by incubation with apoptosed CTLL-2 cell lysate was suppressed by the caspase-3/CPP32-specific tetrapeptide inhibitor in vitro. Therefore, caspase-3/CPP32-like proteases were activated and involved in the cleavage of Bcl-XL protein during CTLL-2 cell apoptosis. We found that Bcl-XL protein was cleaved by caspase-3/CPP32 at two sites in the loop domain (i.e., HLAD61/S and SSLD76/A). The transfection of the carboxy-terminal 18 kDa Bcl-XL fragment increased the sensitivity to apoptosis. These results indicate that caspase-3/CPP32-like proteases cleaved anti-apoptotic Bcl-XL protein and resulted in accelerated apoptotic cell death.
Meng Z, Saei A, Gharibi H, Zhang X, Lyu H, Lundstrom S Anal Chem. 2024; 96(33):13533-13541.
PMID: 39110629 PMC: 11339726. DOI: 10.1021/acs.analchem.4c02051.
Robeldo T, Ribeiro L, Manrique L, Kubo A, Longo E, Camargo E ACS Omega. 2022; 7(21):17563-17574.
PMID: 35664588 PMC: 9161409. DOI: 10.1021/acsomega.1c07046.
Gonneaud A, Fakhir F, Landas E, Le Tallec E, Chartier-Garcia E, Almunia C Int J Mol Sci. 2020; 21(20).
PMID: 33076337 PMC: 7589975. DOI: 10.3390/ijms21207625.
Conformational States of the Cytoprotective Protein Bcl-xL.
Ryzhov P, Tian Y, Yao Y, Bobkov A, Im W, Marassi F Biophys J. 2020; 119(7):1324-1334.
PMID: 32888404 PMC: 7567986. DOI: 10.1016/j.bpj.2020.08.014.
The new role of FF ATP synthase in mitochondria-mediated neurodegeneration and neuroprotection.
Mnatsakanyan N, Jonas E Exp Neurol. 2020; 332:113400.
PMID: 32653453 PMC: 7877222. DOI: 10.1016/j.expneurol.2020.113400.